logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

SENSETIME-W (00020) issues 34,750,600 shares upon vesting of share awards.

date
18:28 10/11/2026
avatar
GMT Eight
SENSETIME-W (00020) announced that on November 10, 2026, it issued 34,750,600 shares upon the vesting of share awards under the 2022 Restricted Share Unit Scheme adopted on June 20, 2022.
SENSETIME-W (00020) announced that on November 10, 2026, it issued 34,750,600 shares upon the vesting of share awards under the 2022 Restricted Share Unit Scheme adopted on June 20, 2022.
Related Articles
China Stock
Hainan Shuangcheng Pharmaceuticals (002693.SZ) passed the drug GMP compliance inspection.
HK Stock
JF SMARTINVEST (09636) repurchased 33,600 shares on November 10 for approximately HK$801,600.
China Stock
Hangzhou AGS Medtech (688581.SH): The controlling shareholder, the actual controller, and the partnership enterprises controlled by them have committed not to reduce their holdings of the company's shares for 6 months.
Hainan Shuangcheng Pharmaceuticals (002693.SZ) passed the drug GMP compliance inspection.
China Stock
JF SMARTINVEST (09636) repurchased 33,600 shares on November 10 for approximately HK$801,600.
HK Stock
Hangzhou AGS Medtech (688581.SH): The controlling shareholder, the actual controller, and the partnership enterprises controlled by them have committed not to reduce their holdings of the company's shares for 6 months.
China Stock
RECOMMEND
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
icon
25/09/2026
From IT Services to Enterprise AI: What ATGL Must Prove Next
From IT Services to Enterprise AI: What ATGL Must Prove Next
icon
24/09/2026
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.